These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7198760)

  • 1. Comment on the commonality of manganese neurotoxicity and Parkinson's disease.
    Graham DG
    Neurotoxicology; 1981 Oct; 2(2):387-8. PubMed ID: 7198760
    [No Abstract]   [Full Text] [Related]  

  • 2. Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease.
    Graham DG
    Neurotoxicology; 1984; 5(1):83-95. PubMed ID: 6538951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical neuropathology of Parkinson's disease.
    Javoy-Agid F; Ruberg M; Taquet H; Bokobza B; Agid Y; Gaspar P; Berger B; N'Guyen-Legros J; Alvarez C; Gray F
    Adv Neurol; 1984; 40():189-98. PubMed ID: 6695594
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemistry and treatment of Parkinson's disease].
    Barbeau A
    Laval Med; 1970 Sep; 41(7):902-5. PubMed ID: 5509487
    [No Abstract]   [Full Text] [Related]  

  • 5. Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease.
    Benedetto A; Au C; Aschner M
    Chem Rev; 2009 Oct; 109(10):4862-84. PubMed ID: 19534496
    [No Abstract]   [Full Text] [Related]  

  • 6. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional anatomy of noradrenergic neurons in Parkinson's disease.
    Soldani P; Fornai F
    Funct Neurol; 1999; 14(2):97-109. PubMed ID: 10399622
    [No Abstract]   [Full Text] [Related]  

  • 8. Manganese neurotoxicity: connecting the dots along the continuum of dysfunction.
    Martin CJ
    Neurotoxicology; 2006 May; 27(3):347-9. PubMed ID: 16337002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced autoxidation of dopamine as a possible basis of manganese neurotoxicity.
    Donaldson J; LaBella FS; Gesser D
    Neurotoxicology; 1981 Jan; 2(1):53-64. PubMed ID: 15622724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter binding in chronic manganese intoxication.
    Huang CC; Weng YH; Lu CS; Chu NS; Yen TC
    J Neurol; 2003 Nov; 250(11):1335-9. PubMed ID: 14648150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for a relationship between manganese and welding and Parkinson's disease.
    Brenner SR
    Neurology; 2006 Feb; 66(3):458-9. PubMed ID: 16476962
    [No Abstract]   [Full Text] [Related]  

  • 12. The neuropathology of manganese-induced Parkinsonism.
    Perl DP; Olanow CW
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):675-82. PubMed ID: 17882011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for a relationship between manganese and welding and Parkinson's disease.
    Jankovic J
    Neurology; 2005 Jun; 64(12):2021-8. PubMed ID: 15985567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease.
    Elsworth JD; Roth RH
    Exp Neurol; 1997 Mar; 144(1):4-9. PubMed ID: 9126143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese neurotoxicity: a review of clinical features, imaging and pathology.
    Pal PK; Samii A; Calne DB
    Neurotoxicology; 1999; 20(2-3):227-38. PubMed ID: 10385886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic implications of manganese neurotoxicity.
    Weiss B
    Neurotoxicology; 2006 May; 27(3):362-8. PubMed ID: 15936082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Parkinson's disease.
    Br Med J; 1978 Apr; 1(6117):872-3. PubMed ID: 25109
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.
    Sossi V; de la Fuente-Fernández R; Schulzer M; Troiano AR; Ruth TJ; Stoessl AJ
    Ann Neurol; 2007 Nov; 62(5):468-74. PubMed ID: 17886297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic innervation of the human striatum in Parkinson's disease.
    Papapetropoulos S; Basel M; Mash DC
    Mov Disord; 2007 Jan; 22(2):286-8. PubMed ID: 17083095
    [No Abstract]   [Full Text] [Related]  

  • 20. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.